
EVAX
Healthcare · Biotechnology · $25.3M market cap
$2.74-0.03 (-1.1%)Nov 13, 4:00 PM EST
Next report
Before the open
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Before the open | — | — | — |
| Aug 20, 2026 | Before the open | -0.01 | -0.50 | -4900.0% |
| May 7, 2026 | Before the open | -0.01 | -0.01 | 0.0% |
| Nov 6, 2025 | Before the open | -0.01 | 0.01 | +200.0% |
| Aug 14, 2025 | Before the open | -0.58 | -1.00 | -72.4% |
| May 27, 2025 | Before the open | -0.70 | -0.50 | +28.6% |
| Mar 25, 2025 | Before the open | -0.15 | -0.07 | +53.3% |
| Oct 31, 2024 | Before the open | -0.60 | -0.20 | +66.7% |
| Aug 14, 2024 | Before the open | -3.50 | -6.00 | -71.4% |
| May 28, 2024 | Before the open | -0.56 | 0.30 | +153.6% |
| Mar 26, 2024 | After the close | -8.00 | -8.00 | 0.0% |
| Dec 19, 2023 | After the close | -9.75 | -10.50 | -7.7% |
| Aug 17, 2023 | After the close | -10.75 | -10.50 |
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its…
| +2.3% |
| Apr 27, 2023 | Before the open | -13.17 | -14.50 | -10.1% |
| Nov 14, 2022 | Before the open | -13.33 | -12.00 | +10.0% |
| Aug 10, 2022 | Before the open | -15.00 | -10.00 | +33.3% |
| May 11, 2022 | Before the open | -0.33 | -0.25 | +24.2% |
| Mar 22, 2022 | Before the open | -15.00 | -19.50 | -30.0% |
| Nov 9, 2021 | Before the open | -17.25 | -13.50 | +21.7% |
| Aug 12, 2021 | Before the open | -14.75 | -18.00 | -22.0% |
| May 13, 2021 | Before the open | -16.50 | -11.50 | +30.3% |
| Jan 25, 2021 | Time not confirmed | -0.25 | -0.19 | +24.0% |